InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ...

InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ...
The CEO mentioned progress in C-GUARDIANS II and III studies, with a commercial launch expected in early 2026. The company is preparing for US launch, expecting enthusiastic adoption at specific sites. They are expanding commercial infrastructure and expect OpEx growth in 2025.